The decline in Bluebird Bio's stock price is directly related to the company's Q4 financial results announcement. Typically, financial results are a strong indicator of a company's health and future prospects. Negative or below-expectation results can lead to a decrease in stock price as investors adjust their expectations for the company's future profitability and growth.